Literature DB >> 6093661

Oncogenic osteomalacia and inappropriate antidiuretic hormone secretion due to oat-cell carcinoma.

H C Taylor, M D Fallon, M E Velasco.   

Abstract

The syndrome of tumor-induced osteomalacia has been previously thought to occur only in association with mesenchymal tumors, although one report has linked prostatic carcinoma with the syndrome. We report the case of a patient who presented first with the clinical and biochemical features of the syndrome of inappropriate antidiuretic hormone secretion, and then oncogenic osteomalacia. The first syndrome was characterized by headaches, nausea, and vomiting; serum sodium determinations ranged between 107 and 118 meq/L with simultaneous urine spot sodium concentrations of 100 to 116 meq/L. The circulating antidiuretic hormone level was markedly elevated to 261.5 microU/mL. The osteomalacia was discovered incidentally when depressed serum phosphorus levels of 1.2 to 1.7 mg/dL were noted in association with 24-hour urine phosphorus excretion exceeding 1000 mg/24 h. Undecalcified tetracycline-labeled bone biopsy samples confirmed oncogenic osteomalacia. Only afterward was a small-cell carcinoma of the lung identified as the likely source of both of these syndromes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6093661     DOI: 10.7326/0003-4819-101-6-786

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  13 in total

Review 1.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

Review 2.  Dual paraneoplastic syndromes: small cell lung carcinoma-related oncogenic osteomalacia, and syndrome of inappropriate antidiuretic hormone secretion: report of a case and review of the literature.

Authors:  Ekamol Tantisattamo; Roland C K Ng
Journal:  Hawaii Med J       Date:  2011-07

3.  Tumour induced hypophosphataemia associated with small cell carcinoma of the bronchus.

Authors:  J Banks; M D Penney; E G Anderson
Journal:  Thorax       Date:  1987-11       Impact factor: 9.139

4.  [Osteomalacia-Clinical aspects, diagnostics and treatment].

Authors:  M Tiefenbach; M Scheel; A Maier; M Gehlen; M Schwarz-Eywill; M Werner; U Siebers-Renelt; M Hammer
Journal:  Z Rheumatol       Date:  2018-10       Impact factor: 1.372

5.  Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.

Authors:  Q L Huang; D S Feig; M E Blackstein
Journal:  J Endocrinol Invest       Date:  2000-04       Impact factor: 4.256

Review 6.  Tumor-Induced Osteomalacia.

Authors:  Pablo Florenzano; Iris R Hartley; Macarena Jimenez; Kelly Roszko; Rachel I Gafni; Michael T Collins
Journal:  Calcif Tissue Int       Date:  2020-06-05       Impact factor: 4.333

7.  Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma.

Authors:  David E Leaf; Renata C Pereira; Hasan Bazari; Harald Jüppner
Journal:  J Clin Endocrinol Metab       Date:  2013-02-07       Impact factor: 5.958

8.  A small cell bronchogenic carcinoma associated with tumoral hypophosphataemia and inappropriate antidiuresis.

Authors:  N Robin; G Gill; C van Heyningen; W Fraser
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

Review 9.  Molecular biology of hypophosphataemic rickets and oncogenic osteomalacia.

Authors:  P S Rowe
Journal:  Hum Genet       Date:  1994-11       Impact factor: 4.132

10.  Oncogenic hypophosphataemia and ectopic corticotrophin secretion due to oat cell carcinoma of the trachea.

Authors:  C van Heyningen; A R Green; I A MacFarlane; C T Burrow
Journal:  J Clin Pathol       Date:  1994-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.